Physician profile
Rui Wang
NPI 1205218682
$3,952.93
in general payments reported to CMS, 2019-2025
13 companies · $364 in 2025
The $364 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $200 · 2021: $1,334 · 2022: $160 · 2023: $835 · 2024: $929 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,127.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,028.98 | 2021 | |
| Coloplast Corp | $873.25 | 2021-2025 | Altis, Speedicath |
| Axonics, INC. | $408.41 | 2022-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $390.10 | 2023-2025 | Solyx Sis System, Advantage System, Axonics |
| Abbvie INC. | $367.52 | 2023-2025 | Botox |
| Baxter Healthcare | $240.97 | 2023-2024 | Starling System, Tisseel, Floseal |
| Coopersurgical, INC. | $200.00 | 2020 | |
| Medtronic USA, INC. | $131.73 | 2019 | |
| Astellas Pharma US INC | $99.24 | 2025 | Izervay |
| Sumitomo Pharma America, INC. | $73.09 | 2023-2025 | Gemtesa |
| Medtronic, INC. | $72.50 | 2023 | Interstim |
| Caldera Medical, INC | $50.82 | 2022 | |
| Urovant Sciences INC | $16.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rui Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.